Sílvio Melo Torres

ORCID: 0000-0001-7274-3602
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Gastric Cancer Management and Outcomes
  • Neuroendocrine Tumor Research Advances
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lung Cancer Research Studies
  • Gastrointestinal Tumor Research and Treatment
  • Metastasis and carcinoma case studies
  • Gallbladder and Bile Duct Disorders
  • Colorectal Cancer Treatments and Studies
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Esophageal and GI Pathology
  • Neuroblastoma Research and Treatments
  • Pancreatitis Pathology and Treatment
  • Renal cell carcinoma treatment
  • Minimally Invasive Surgical Techniques
  • Cancer Research and Treatments
  • Aging, Health, and Disability
  • Essential Oils and Antimicrobial Activity
  • Foreign Body Medical Cases
  • Psychological Treatments and Disorders
  • Oral and gingival health research
  • Radiomics and Machine Learning in Medical Imaging
  • Tracheal and airway disorders

AC Camargo Hospital
2019-2024

Molecular Oncology (United States)
2019

Hospital Geral de Fortaleza
2016

Universidade Federal do Ceará
2008

Hyperthermic intraperitoneal chemotherapy (HIPEC) has been associated with improved survival when compared surgery alone for non-metastatic gastric cancer patients in randomized trials and meta-analyses. However, little evidence is available regarding the use of HIPEC nonmetastatic who are treated perioperative radical surgery. The aim this study was to investigate putative benefit subgroup surgery.This a retrospective cohort that included gastroesophageal junction were curative resection...

10.1002/jso.25823 article EN Journal of Surgical Oncology 2020-01-16

Abstract Background Hepatic metastases are a major cause of death in patients with colorectal cancer. A comprehensive assessment the prognostic factors associated long‐term survival could improve patient selection for surgical approaches and decrease morbidity futile locoregional treatments. Methods We performed retrospective analysis who underwent hepatectomy liver at single center from 2000 to 2012. Results To identify 5‐ 10‐year overall (OS) disease‐free (DFS), we analyzed 280 150...

10.1002/jso.25893 article EN Journal of Surgical Oncology 2020-03-09

To analyze determinants of prognosis in patients with bronchial carcinoid tumors treated surgically and the potential concomitance such second primary neoplasms.This was a retrospective analysis 51 between 2007 2016. Disease-free survival (DFS) calculated by Kaplan-Meier method, were evaluated. Primary neoplasms that concomitant identified reviewing patient charts.The median age 51.2 years, 58.8% female, 52.9% asymptomatic. The most common histology typical (in 80.4%). Five-year DFS 89.8%....

10.1590/1806-3713/e20180140 article EN cc-by-nc Jornal Brasileiro de Pneumologia 2019-01-01

Abstract Introduction Pancreatic malignant tumors are resectable at diagnosis in only 15% to 20% of cases and invasion vascular structures is commonly present. Therefore, extended resections needed for adequate local control negative margins. However, morbidity mortality associated with these enlarged limiting factors. The aim this study was correlate demographic technical aspects that influenced early late outcomes. Materials Methods Between October 2007 May 2019, 523 pancreatic surgeries...

10.1002/jso.25799 article EN Journal of Surgical Oncology 2019-12-06

To describe the patterns of disease relapse and follow-up patients with resected pancreatic adenocarcinoma. Additionally, we looked at patients' characteristics survival.We included potentially resectable adenocarcinoma diagnosed from 2008 to 2018 who were submitted resection clear macroscopic margins started posttreatment surveillance.The study population consists 73 patients. The median interval between imaging studies was 3.2 months during first 2 years 5.1 thereafter. Forty-eight (65.8%)...

10.1002/jso.26985 article EN Journal of Surgical Oncology 2022-06-14

The incidence, predictive, and prognostic impact of programmed cell death (PD-L1) expression in gastric (GC) gastroesophageal junction tumors (GEJC) treated with perioperative chemotherapy is poorly understood. We aimed to assess PD-L1 by immunohistochemistry (IHC) both pre posttreatment specimens evaluating its on pathological response survival outcomes.Retrospective cohort patients GC GEJ a single western cancer center between 2007 2017. was assessed IHC before after neoadjuvant...

10.1002/jso.26929 article EN Journal of Surgical Oncology 2022-06-11

Hepatectomies associated with vascular resections pose a technical challenge for surgeons, involving multiple reconstruction techniques. Moreover, adding clinical and surgical risks in the postoperative setting of these complex procedures are mainly due to prolonged periods potential complications inherent manipulation. Leveraging expertise Cancer Center, we propose an institutional assessment utilizing case series from A. C. Camargo Center hepatectomies resection, evaluating outcomes while...

10.1002/jso.27718 article EN Journal of Surgical Oncology 2024-08-05

Introduction Koro, also known in Cantonese as Shook Yang , which literally translates to “shrinking penis”, has its roots a cultural belief that mythological figure would steal the penis of his victims. Predominantly reported Southeast Asia, it involves an acute fear genital retraction, often accompanied by this retraction may lead death. Over last two centuries, Koro undergone several attempts establish definition and classification, without true consensus having been reached. Objectives...

10.1192/j.eurpsy.2024.561 article EN cc-by-nc-nd European Psychiatry 2024-04-01

ABSTRACT Background Gastric cancer is the fifth most common neoplasm and third leading cause of cancer‐related death worldwide. Neoadjuvant chemotherapy recommended for Stages II–III resectable tumors, but comparative effectiveness minimally invasive surgery (MIS) versus open gastrectomy (OG) post‐neoadjuvant therapy has not been adequately investigated. Methods A retrospective cohort analysis was performed on patients with clinical Stage II III gastric adenocarcinoma who underwent...

10.1002/jso.27904 article EN Journal of Surgical Oncology 2024-09-19

cases between 10-15 years of operation in patients whose initial lesion was malignant.In gastrectomy for peptic ulcer disease the peak incidence occurred around fourth decade after 9 .Gastric stump cancer surgically treated has bad prognosis.Was observed lower five-year survival with gastric than those primary 10 .The treatment choice is surgical D2 resection remaining stomach, plus lymphadenectomy including organs and other adjacent lymph nodes 3 .To improve results necessary early...

10.1590/0102-6720201600010018 article EN ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2016-03-01

Abstract Background and Objectives We aimed to describe the routine clinical practice of physicians involved in treatment patients with localized pancreatic ductal adenocarcinoma (PDAC) Brazil. Methods Physicians were invited through email text messages participate an electronic survey sponsored by Brazilian Gastrointestinal Tumor Group (GTG) Society Surgical Oncology (SBCO). evaluated relationship between variable categories numerically false discovery rate‐adjusted Fisher's exact test p...

10.1002/jso.27453 article EN Journal of Surgical Oncology 2023-10-05

e16569 Background: The incidence, prognostic and predictive impacts of PD-L1 expression in locally advanced gastric cancer is unknown. We aimed to determine the by CPS pre-treatment biopsy surgical specimens patients (pts) with who received neoadjuvant therapy its association pathological response survival outcomes. Methods: Retrospective cohort pts treated at a center from 2007 2017. Pts confirmed or GEJ adenocarcinoma treatment curative-intent D2 surgery were included. Gastric stump tumors...

10.1200/jco.2020.38.15_suppl.e16569 article EN Journal of Clinical Oncology 2020-05-20
Coming Soon ...